Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.
The global Human Milk Oligosaccharides (HMO) market is valued at 110 million US$ in 2018 is expected to reach 720 million US$ by the end of 2025, growing at a CAGR of 27.0% during 2019-2025.
This report focuses on Human Milk Oligosaccharides (HMO) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Milk Oligosaccharides (HMO) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Segment by Regions
Segment by Type
Segment by Application